XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -19.90%98.63M | 13.40%139.98M | -70.38%123.13M | -86.17%123.43M | 2.22%415.66M | 100.34%892.75M | 144.32%406.62M | 77.82%445.63M | --166.43M | 140.25%250.6M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 25.06%-1.34M | 90.06%-2.81M | 58.78%-1.79M | -367.36%-28.24M | -1.74%-4.34M | -147.32%-6.04M | -267.90%-4.26M | -73.26%-2.44M | ---1.16M | -23.04%-1.41M |
Investment loss (gain) | ---- | 28.94%-1.36M | ---697K | 4.82%-1.91M | ---- | ---2.01M | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | -173.34%-5.48M | -102.75%-6.5M | -15.31%-2M | -187.87%-3.2M | -28.76%-1.74M | 41.76%-1.11M | -44.43%-1.35M | 1.44%-1.91M | ---934K | -343.59%-1.94M |
Impairment and provisions: | 3.15%215.03M | -7.15%528.79M | 2,986.26%208.48M | 3,149.34%569.51M | 254.22%6.76M | 71.63%17.53M | 51.11%1.91M | 25.09%10.21M | --1.26M | 130.88%8.16M |
-Impairment of goodwill | -30.46%55.44M | 78.39%255.84M | --79.72M | --143.42M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | 23.95%159.59M | -35.94%272.95M | 1,806.05%128.75M | 2,331.08%426.1M | 254.22%6.76M | 71.63%17.53M | 51.11%1.91M | 25.09%10.21M | --1.26M | 130.88%8.16M |
Revaluation surplus: | ---- | -85.28%1.58M | ---- | --10.72M | ---- | ---- | ---- | ---- | ---- | ---- |
-Fair value of investment properties (increase) | ---- | --1.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | --10.72M | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | 644.32%1.01M | -137.67%-1.22M | -96.81%-185K | -284.33%-515K | -276.00%-94K | -282.86%-134K | -135.21%-25K | 82.32%-35K | --71K | ---198K |
-Loss (gain) on sale of property, machinery and equipment | 2.16%-181K | -137.67%-1.22M | -96.81%-185K | -284.33%-515K | -276.00%-94K | -282.86%-134K | -135.21%-25K | 82.32%-35K | --71K | ---198K |
-Loss (gain) from selling other assets | --1.19M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | -11.91%72.38M | 10.44%166.08M | 49.71%82.16M | 243.24%150.38M | 211.72%54.88M | 49.67%43.81M | 22.22%17.61M | 15.27%29.27M | --14.4M | 470.40%25.39M |
-Amortization of intangible assets | -9.15%60.27M | 9.62%131.25M | 62.93%66.34M | 269.89%119.73M | 203.82%40.72M | 43.04%32.37M | 21.24%13.4M | 11.33%22.63M | --11.05M | 2,136.08%20.33M |
Financial expense | -1.09%17.46M | 54.82%35.46M | 1,122.94%17.65M | 8,676.25%22.91M | 1,274.29%1.44M | -17.67%261K | -35.19%105K | -9.69%317K | --162K | 76.38%351K |
Special items | -40.98%923K | -79.07%1.62M | 1.10%1.56M | 68.24%7.74M | 160.88%1.55M | 388.64%4.6M | 72.89%593K | --942K | --343K | ---- |
Operating profit before the change of operating capital | -6.93%398.61M | 1.27%861.63M | -9.66%428.31M | -10.41%850.82M | 12.56%474.11M | 97.03%949.66M | 133.24%421.2M | 71.54%481.98M | --180.58M | 150.54%280.97M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 26.98%-594.73M | ---- | -74.77%-814.44M | ---- | -1,930.03%-466.01M | ---- | 90.17%-22.96M | ---- | -104.61%-233.44M |
Accounts payable increase (decrease) | ---- | 15.66%-184.96M | ---- | 76.72%-219.3M | ---- | -30.80%-941.84M | ---- | -429.66%-720.06M | ---- | -40.69%218.42M |
prepayments (increase)decrease | ---- | -166.63%-354.53M | ---- | -37.57%532.13M | ---- | 46.52%852.3M | ---- | 3,702.22%581.69M | ---- | 94.12%-16.15M |
Special items for working capital changes | 20.74%-449.81M | 265.38%39.68M | -171.76%-567.5M | -1,479.64%-23.99M | -452.96%-208.82M | -95.15%1.74M | 33.58%-37.77M | 11.58%35.82M | ---56.86M | 3,243.96%32.1M |
Cash from business operations | 63.22%-51.2M | -171.62%-232.92M | -152.47%-139.19M | -17.84%325.22M | -30.81%265.29M | 11.04%395.85M | 209.90%383.43M | 26.45%356.47M | --123.73M | 203.93%281.9M |
Other taxs | 31.73%-50.98M | -22.06%-145.3M | 31.61%-74.67M | 6.50%-119.04M | -2.40%-109.18M | -49.69%-127.31M | -124.43%-106.63M | -261.06%-85.05M | ---47.51M | -0.75%-23.56M |
Interest received - operating | -25.06%1.34M | -90.06%2.81M | -58.78%1.79M | 367.36%28.24M | 1.74%4.34M | 147.32%6.04M | 267.90%4.26M | 73.26%2.44M | --1.16M | 23.04%1.41M |
Interest paid - operating | 62.60%-144K | 11.52%-361K | 73.32%-385K | -56.32%-408K | -1,274.29%-1.44M | 17.67%-261K | 35.19%-105K | 9.69%-317K | ---162K | -76.38%-351K |
Net cash from operations | 52.47%-100.98M | -260.58%-375.77M | -233.62%-212.46M | -14.70%234.01M | -43.41%159M | 0.28%274.32M | 263.88%280.96M | 5.45%273.55M | --77.21M | 268.89%259.41M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | --1.66M | -59.27%1.84M | ---- | --4.51M | ---- | ---- | ---- | ---- | ---- | ---- |
Loan receivable (increase) decrease | -47.96%191K | -99.93%361K | 100.07%367K | 159.43%521.47M | ---524.93M | -1,242.27%-877.44M | ---- | -216.55%-65.37M | ---154.72M | -106.90%-20.65M |
Sale of fixed assets | -71.10%854K | 340.86%9.51M | 178.25%2.96M | 353.89%2.16M | 3,833.33%1.06M | 46.15%475K | -88.46%27K | 55.50%325K | --234K | --209K |
Purchase of fixed assets | 21.92%-3.96M | 42.77%-12.79M | 58.85%-5.07M | -389.98%-22.34M | -501.61%-12.31M | -55.00%-4.56M | -99.03%-2.05M | -82.51%-2.94M | ---1.03M | 37.90%-1.61M |
Purchase of intangible assets | -1,398.63%-6.55M | -31.58%-3.08M | 73.88%-437K | -138.59%-2.34M | -142.46%-1.67M | 86.40%-982K | ---690K | ---7.22M | ---- | ---- |
Sale of subsidiaries | --764K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | -141.74%-62.3M | -126.20%-49.8M | 107.87%149.26M | 240.39%190.08M | -2,722.58%-1.9B | ---135.4M | -1,045.67%-67.21M | ---- | --7.11M |
Recovery of cash from investments | ---- | -51.39%158.36M | -32.87%50.7M | 41.16%325.76M | --75.52M | --230.78M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | 51.45%-157.24M | 33.01%-50.24M | -30.74%-323.85M | ---75M | ---247.71M | ---- | ---- | ---- | ---- |
Net cash from investment operations | 86.35%-7.03M | -109.98%-65.35M | 85.16%-51.52M | 123.41%654.62M | -151.43%-347.25M | -1,863.58%-2.8B | 11.19%-138.11M | -852.81%-142.42M | ---155.52M | -105.17%-14.95M |
Net cash before financing | 59.08%-108.01M | -149.64%-441.12M | -40.23%-263.98M | 135.23%888.63M | -231.78%-188.25M | -2,023.37%-2.52B | 282.43%142.85M | -46.36%131.13M | ---78.31M | -31.96%244.46M |
Cash flow from financing activities | ||||||||||
New borrowing | -93.42%40M | 1,695.85%646.51M | 22.51%607.84M | -96.35%36M | --496.14M | 123.64%985.37M | ---- | 8,557.89%440.6M | --167.3M | 69.63%5.09M |
Refund | 87.49%-64.7M | -264.16%-561.05M | -4,004.15%-517.16M | -308,034.00%-154.07M | ---12.6M | 99.99%-50K | ---- | -8,505.73%-473.32M | ---1M | 98.74%-5.5M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.62B | ---- | ---- |
Interest paid - financing | -0.28%-17.31M | -56.03%-35.1M | ---17.26M | ---22.5M | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid - financing | ---23.5M | 96.07%-4.98M | ---- | 5.10%-126.76M | ---4.73M | -17,521.24%-133.57M | ---- | -127.63%-758K | ---- | ---333K |
Absorb investment income | ---- | ---- | ---- | -37.50%250K | -91.98%150K | -50.00%400K | --1.87M | --800K | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | 95.54%-2.98M | ---- | ---66.71M | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---34.55M | ---34.55M | ---- |
Net cash from financing operations | -196.65%-66.35M | 113.25%36.49M | -85.53%68.65M | -132.72%-275.5M | 484,160.20%474.38M | -66.12%841.99M | -100.08%-98K | 67,582.38%2.49B | --129.64M | 99.16%-3.68M |
Effect of rate | -97.14%1K | -97.95%16K | -91.38%35K | 101.71%782K | 101.56%406K | 37.75%-45.85M | ---25.95M | ---73.65M | ---- | ---- |
Net Cash | 10.74%-174.36M | -165.99%-404.63M | -168.27%-195.34M | 136.49%613.12M | 100.43%286.13M | -164.21%-1.68B | 178.10%142.76M | 986.70%2.62B | --51.33M | 410.62%240.78M |
Begining period cash | -21.90%1.44B | 49.77%1.85B | 49.77%1.85B | -58.32%1.23B | -58.32%1.23B | 610.14%2.96B | 610.14%2.96B | 136.81%416.77M | --416.77M | -30.58%175.99M |
Cash at the end | -23.22%1.27B | -21.90%1.44B | 8.69%1.65B | 49.77%1.85B | -50.59%1.52B | -58.32%1.23B | 557.22%3.08B | 610.14%2.96B | --468.1M | 136.81%416.77M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.